Back to User profile » Ms Chieh-I Chen
Papers published by Ms Chieh-I Chen:
Real-World Treatment Patterns and Outcomes of Cemiplimab in Patients with Advanced Cutaneous Squamous Cell Carcinoma Treated in US Oncology Practices
Ge W, Wu N, Chen CI, Inocencio TJ, LaFontaine PR, Seebach F, Fury M, Harnett J, Ruiz ES
Cancer Management and Research 2024, 16:841-854
Published Date: 18 July 2024
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Sarilumab monotherapy compared with adalimumab monotherapy for the treatment of moderately to severely active rheumatoid arthritis: an analysis of incremental cost per effectively treated patient
Fournier M, Chen C, Kuznik A, Proudfoot C, Mallya UG, Michaud K
ClinicoEconomics and Outcomes Research 2019, 11:117-128
Published Date: 5 February 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Budget impact analysis of sarilumab for the treatment of rheumatoid arthritis in patients with an inadequate response to conventional synthetic DMARD or TNF inhibitor therapies [Corrigendum]
Ferrufino CP, Munakata J, Wei W, Proudfoot C, Kuznik A, Boklage SH, Chen C
ClinicoEconomics and Outcomes Research 2019, 11:83-85
Published Date: 14 January 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Budget impact analysis of sarilumab for the treatment of rheumatoid arthritis in patients with an inadequate response to conventional synthetic DMARD or TNF inhibitor therapies
Ferrufino CP, Munakata J, Wei W, Proudfoot C, Kuznik A, Boklage SH, Chen C
ClinicoEconomics and Outcomes Research 2018, 10:805-819
Published Date: 16 November 2018
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Treatment effectiveness and treatment patterns among rheumatoid arthritis patients after switching from a tumor necrosis factor inhibitor to another medication
Bonafede MMK, Curtis JR, McMorrow D, Mahajan P, Chen C
ClinicoEconomics and Outcomes Research 2016, 8:707-715
Published Date: 2 December 2016